CD8A and neoplasm: Additionally, recent research indicates that PDGFB-based nanocomposites may enhance the movement and infiltration of natural killer cells, macrophages that exhibit an M1 phenotype, and CD8+ T cells, thereby strengthening antitumor immune response and curtailing tumor growth.